Micregen is pleased to announce its sponsorship of the 37th International Symposium on Pediatrics Surgical Research 2024, to be held at the Karolinska Institute in Stockholm, Sweden. This conference will unite clinicians and researchers from around the globe who are engaged in pioneering research on various aspects of pediatric diseases.
Our novel investigational therapy, Secretomix®, has demonstrated promising potential in addressing rare diseases in children, including orphan-designated conditions such as Necrotising Enterocolitis (NEC), where current treatment options remain extremely limited.
Micregen is committed to improving healthcare for diseases that can benefit from regenerative therapeutic approaches, and we are excited about the opportunity to engage with fellow professionals, researchers, and innovators in this crucial area. Rob Mitchell, our Head of Development, will be attending the conference from 19th to 21st September and looks forward to meeting attendees there.